Non-canonical signalling and roles of the vasoactive peptides angiotensins and kinins. (Q38190099)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559183%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

review article

1 reference

title

Non-canonical signalling and roles of the vasoactive peptides angiotensins and kinins (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559183%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559183%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Diego A Duarte

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559183%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Vanessa Lima

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559183%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Andrea G Maria

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559183%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Erika C Prando

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559183%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Deisy Y Rodríguez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559183%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Geisa A Santos

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559183%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Pedro P C Souza

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559183%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Lucas T Parreiras-E-Silva

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559183%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

English

0 references

publication date

1 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559183%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559183%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559183%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

753-774

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559183%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559183%20AND%20SRC:MED&resulttype=core&format=json

Intramuscular renin-angiotensin system is activated in human muscular dystrophy.

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Immunohistochemical detection of angiotensin II receptors in mouse cerebellum and adrenal gland using "in vivo cryotechnique".

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human ocular tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Pharmacological characterization of angiotensin II binding sites in the canine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin II AT2 receptor localization in cardiovascular tissues by its antibody developed in AT2 gene-deleted mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Immunohistochemical localization of the angiotensin-(1-7) receptor Mas in the murine forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin-(1-7), its receptor Mas, and the angiotensin-converting enzyme type 2 are expressed in the human ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin (1-7) and its receptor Mas are expressed in the human testis: implications for male infertility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Brain kinin B₁ receptor contributes to the onset of stereotypic nocifensive behavior in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Activation of kinin B1 receptor evokes hyperthermia through a vagal sensory mechanism in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

IL-4 and IL-13 inhibit IL-1β and TNF-α induced kinin B1 and B2 receptors through a STAT6-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Effects of kinin B(1) and B(2) receptor antagonists on overactive urinary bladder syndrome induced by spinal cord injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Activation of TRPV1 by capsaicin induces functional kinin B(1) receptor in rat spinal cord microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Enalaprilat-mediated activation of kinin b(1) receptors and vasodilation in the rat isolated perfused kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Blockade of the kinin B1 receptor ameloriates glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Nicotine enhances murine airway contractile responses to kinin receptor agonists via activation of JNK- and PDE4-related intracellular pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Kinin-B2 receptor activity determines the differentiation fate of neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Lack of kinin B₁ receptor potentiates leptin action in the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Bradykinin B2 receptor in the adrenal medulla of male rats and mice: glucocorticoid-dependent increase with immobilization stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Attenuation of persistent experimental pancreatitis pain by a bradykinin b2 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Mechanisms through which bradykinin promotes glomerular injury in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin II-independent angiotensin-(1-7) formation in rat hippocampus: involvement of thimet oligopeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Secondary signalling mechanisms in angiotensin II-stimulated vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Role of calcium influx and intracellular calcium stores in angiotensin II-mediated calcium hyper-responsiveness in smooth muscle from spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Cell type-specific angiotensin II-evoked signal transduction pathways: critical roles of Gbetagamma subunit, Src family, and Ras in cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin II responses of vascular smooth muscle cells from hypertensive rats: enhancement at the level of p42 and p44 mitogen activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Involvement of the Gi/o/cGMP/PKG pathway in the AT2-mediated inhibition of outer cortex proximal tubule Na+-ATPase by Ang-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

PKA-mediated effect of MAS receptor in counteracting angiotensin II-stimulated renal Na+-ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis: a potential target for treating thrombotic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Role of angiotensin AT(2) receptors in natriuresis: Intrarenal mechanisms and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Focus on Brain Angiotensin III and Aminopeptidase A in the Control of Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Adenoviral delivery of angiotensin-(1-7) or angiotensin-(1-9) inhibits cardiomyocyte hypertrophy via the mas or angiotensin type 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Stimulation of ANP by angiotensin-(1-9) via the angiotensin type 2 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Bradykinin-induced transient accumulation of inositol trisphosphate in neuron-like cell line NG108-15 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Differential G protein-mediated coupling of neurotransmitter receptors to Ca2+ channels in rat dorsal root ganglion neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Differential involvement of Galpha12 and Galpha13 in receptor-mediated stress fiber formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Characterization of bradykinin receptors in a human osteoblastic cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Signal characteristics of G protein-transactivated EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Transactivation joins multiple tracks to the ERK/MAPK cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

EGF receptor activation by GPCRs: an universal pathway reveals different versions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Receptor type protein tyrosine phosphatase-kappa mediates cross-talk between transforming growth factor-beta and epidermal growth factor receptor signaling pathways in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Signaling pathways of isoproterenol-induced ERK1/2 phosphorylation in primary cultures of astrocytes are concentration-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Sphingosine 1-phosphate transactivates c-Met as well as epidermal growth factor receptor (EGFR) in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Differential requirement of the epidermal growth factor receptor for G protein-mediated activation of transcription factors by lysophosphatidic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

GPCR agonist-induced transactivation of the EGFR upregulates MLC II expression and promotes hypertension in insulin-resistant rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Recent advances in angiotensin II signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

EGF receptor transactivation is obligatory for protein synthesis stimulation by G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

ADAM17 silencing by adenovirus encoding miRNA-embedded siRNA revealed essential signal transduction by angiotensin II in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Caveolin interacts with the angiotensin II type 1 receptor during exocytic transport but not at the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

beta-Arrestin: a protein that regulates beta-adrenergic receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Identification of a motif in the carboxyl terminus of beta -arrestin2 responsible for activation of JNK3

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Protease-activated receptor-2 simultaneously directs beta-arrestin-1-dependent inhibition and Galphaq-dependent activation of phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

How does arrestin assemble MAPKs into a signaling complex?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Dynamin and beta-arrestin reveal distinct mechanisms for G protein-coupled receptor internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Differential roles of arrestin-2 interaction with clathrin and adaptor protein 2 in G protein-coupled receptor trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

beta-Arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The ADP ribosylation factor nucleotide exchange factor ARNO promotes beta-arrestin release necessary for luteinizing hormone/choriogonadotropin receptor desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Identification of NSF as a beta-arrestin1-binding protein. Implications for beta2-adrenergic receptor regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Constitutive ERK1/2 activation by a chimeric neurokinin 1 receptor-beta-arrestin1 fusion protein. Probing the composition and function of the G protein-coupled receptor "signalsome".

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

β-Arrestin1 Mediates Insulin-like Growth Factor 1 (IGF-1) Activation of Phosphatidylinositol 3-Kinase (PI3K) and Anti-apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Cardiorenal actions of TRV120027, a novel ß-arrestin-biased ligand at the angiotensin II type I receptor, in healthy and heart failure canines: a novel therapeutic strategy for acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

GPCR biased ligands as novel heart failure therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Molecular signatures of G-protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Genetic variation in G-protein-coupled receptors--consequences for G-protein-coupled receptors as drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Bradykinin B(2) receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Bradykinin B2 receptor activates extracellular signal-regulated protein kinase in mIMCD-3 cells via epidermal growth factor receptor transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Activation of kinin B1 receptor increases the release of metalloproteases-2 and -9 from both estrogen-sensitive and -insensitive breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Stimulation of the bradykinin B(1) receptor induces the proliferation of estrogen-sensitive breast cancer cells and activates the ERK1/2 signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Signal transduction pathways of G protein-coupled receptors and their cross-talk with receptor tyrosine kinases: lessons from bradykinin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Bradykinin decreases podocyte permeability through ADAM17-dependent epidermal growth factor receptor activation and zonula occludens-1 rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Cardioprotection of bradykinin at reperfusion involves transactivation of the epidermal growth factor receptor via matrix metalloproteinase-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Collagenase-2 and -3 mediate epidermal growth factor receptor transactivation by bradykinin B2 receptor in kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Bradykinin B2 receptor interacts with integrin alpha5beta1 to transactivate epidermal growth factor receptor in kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Bradykinin-mediated cell proliferation depends on transactivation of EGF receptor in corneal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Kinin b2 receptor mediates induction of cyclooxygenase-2 and is overexpressed in head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Activation of kinin B receptor triggers differentiation of cultured human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Peptide and non-peptide bradykinin receptor antagonists: role in allergic airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Synthesis and characterization of bradykinin B(2) receptor agonists containing constrained dipeptide mimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Small molecule bradykinin B1 receptor antagonists as potential therapeutic agents for pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Bradykinin receptor ligands: therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Characterization of dual agonists for kinin B1 and B2 receptors and their biased activation of B2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The β-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Functionally selective AT(1) receptor activation reduces ischemia reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The renin-angiotensin system and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin receptors: a new role in cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Cancer, inflammation and the AT1 and AT2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Activation of invasiveness of cervical carcinoma cells by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin II drives the production of tumor-promoting macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Retinal expression of vascular endothelial growth factor is mediated by angiotensin type 1 and type 2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Which, if any, antihypertensive agents cause cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin receptor blockers and tumorigenesis: something to be (or not to be) concerned about?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Inhibition of human lung cancer cell growth by angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

A comparison of the effects of Angiotensin IV on androgen-dependent and androgen-independent prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Evaluation of role of angiotensin III and aminopeptidases in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Participation of kallikrein-kinin system in different pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Expression patterns of kinin-dependent genes in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Expression of tissue and plasma kallikreins and kinin B1 and B2 receptors in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Expression of components of the kallikrein-kinin system in human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Pituitary adenomas with high and low basal inositol phospholipid turnover; the stimulatory effect of kinins and an association with interleukin-6 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

A Novel Mitogenic Signaling Pathway of Bradykinin in the Human Colon Carcinoma Cell Line SW-480 Involves Sequential Activation of a Gq/11 Protein, Phosphatidylinositol 3-Kinase , and Protein Kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Agonist stimulation of B1 and B2 kinin receptors causes activation of the MAP kinase signaling pathway, resulting in the translocation of AP-1 in HEK 293 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Bradykinin promotes the chemotactic invasion of primary brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Bradykinin enhances cell migration in human prostate cancer cells through B2 receptor/PKCδ/c-Src dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Bradykinin-induced chemotaxis of human gliomas requires the activation of KCa3.1 and ClC-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The kallikrein-kinin-system in head and neck squamous cell carcinoma (HNSCC) and its role in tumour survival, invasion, migration and response to radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Activation of the kinin B1 receptor attenuates melanoma tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The CNS renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Brain renin-angiotensin--a new look at an old system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Brain and peripheral angiotensin II play a major role in stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Inhibition of the renin-angiotensin system prevents seizures in a rat model of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Cognitive effects attributed to angiotensin II may result from its conversion to angiotensin IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin IV and LVV-haemorphin 7 enhance spatial working memory in rats: effects on hippocampal glucose levels and blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The brain RAS and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Deciphering the mechanism underlying late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Fyn is involved in angiotensin II type 2 receptor-induced neurite outgrowth, but not in p42/p44mapk in NG108-15 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Brain renin angiotensin in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The role of the central renin-angiotensin system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Kinins and kinin receptors in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Dual kinin B1 and B2 receptor activation provides enhanced blood-brain barrier permeability and anticancer drug delivery into brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Multifunctional effects of bradykinin on glial cells in relation to potential anti-inflammatory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Human kallikrein 6 as a biomarker of alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Bradykinin-induced amyloid precursor protein secretion: a protein kinase C-independent mechanism that is not altered in fibroblasts from patients with sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Autoradiographic analysis of rat brain kinin B1 and B2 receptors: normal distribution and alterations induced by epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Hyperinsulinemia: effect on cardiac mass/function, angiotensin II receptor expression, and insulin signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Interaction between Adiponectin and Aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Regulation of cardiac hypertrophy by intracellular signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Regulation of insulin secretion and reactive oxygen species production by free fatty acids in pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The influence of body mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin II affects basal, pulsatile, and glucose-stimulated insulin secretion in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin receptor blockade increases pancreatic insulin secretion and decreases glucose intolerance during glucose supplementation in a model of metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Of diabetic mice and ACE2: a new biomarker of renal disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin-(1-7) and the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The sweeter side of ACE2: physiological evidence for a role in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Beneficial effects of the activation of the angiotensin-(1-7) MAS receptor in a murine model of adriamycin-induced nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Des-aspartate-angiotensin-I and angiotensin IV improve glucose tolerance and insulin signalling in diet-induced hyperglycaemic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Glucose transport activity in insulin-resistant rat muscle. Effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Role of the B(2) receptor of bradykinin in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

The kallikrein-kinin system in health and in diseases of the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Kinins in cardiac inflammation and regeneration: insights from ischemic and diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Use of beta-blockers and risk of fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin II accelerates osteoporosis by activating osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Physiological function of the angiotensin AT1a receptor in bone remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Angiotensin II type 2 receptor blockade increases bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Activation of renin-angiotensin system induces osteoporosis independently of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Bradykinin stimulates bone resorption and lysosomal-enzyme release in cultured mouse calvaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Evidence for BK1 bradykinin-receptor-mediated prostaglandin formation in osteoblasts and subsequent enhancement of bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Kinin B1 and B2 receptor expression in osteoblasts and fibroblasts is enhanced by interleukin-1 and tumour necrosis factor-alpha. Effects dependent on activation of NF-kappaB and MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

A tissue kallikrein in the synovial fluid of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Kinin generation in the gingival inflammatory response to topically applied bacterial lipopolysaccharides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Bradykinin enhances GLUT4 translocation through the increase of insulin receptor tyrosine kinase in primary adipocytes: evidence that bradykinin stimulates the insulin signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

Augmented plasma and tissue kallikrein like activity in synovial fluid of patients with inflammatory articular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130414

21 January 2018

Identifiers

DOI

10.1042/CS20130414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24559183%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference